- Patients can check HIV tests at 143 selected centers of Metropolis Healthcare across Mumbai
- Marathi celebs Subodh Bhave, ShivajiSatam& Dr. Nilesh Sabale to endorse the campaign
Mumbai, December 04, 2018: On the occasion of 30th anniversary of the World AIDS Day, Mumbai District AIDS Control Society (MDACS) has partnered with Metropolis Healthcare Limited, one of the largest chains of diagnostics in India. MDACS is a part of National AIDS Control Organisation (NACO).
In accordance with this year’s World AIDS Day theme of ‘Know your status’, MDACS has planned a campaign to encourage people to actively seek HIV testing by reducing stigma and discrimination associated with HIV test.
Under the partnership between MDACS and Metropolis Healthcare, a unique campaign titled “Know Your Status” has been launched between 1stof December 2018 to 7th December 2018, whereby patients across Mumbai can avail HIV testing Facility of Metropolis Healthcare Ltd at selected 143 centers in Mumbai, with a fee as nominal as Rs 75/- per test.The free HIV testing services are available in 222 government /MCGM hospitals, maternity homes and dispensaries in the city. The addresses of all the centers can be found on the Metropolis Healthcare Website: https://www.metropolisindia.com/patients/know-your-status/
Commenting on this partnership with MDACS and launch of the campaign “Know Your Status”, Dr Sushil Shah, Chairman, Metropolis Healthcare Limited said, “Today globally three in four people living with HIV know their status but we still have miles to go as the latest UNAIDS report shows. Through this initiative, Metropolis Healthcare will urge people at large to come forward and do their HIV tests. An early detection can save not only lives of patients but also, will help the families dependent on the patient.”
Various celebrities in Marathi film industry Mr. Subodh Bhave, Mr. ShivajiSatam, Dr. Nilesh Sabale and others have strongly endorsed the campaign ‘Know Your Status and Ensure Safe Life to Your Loved Ones’!
Join us this World AIDS Day in raising awareness about the importance of knowing one’s status!
METROPOLIS HEALTHCARE LIMITED is proposing, subject to, applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the Draft Red Herring Prospectus with SEBI. The Draft Red Herring Prospectus shall be available on the websites of SEBI, BSE, NSE at www.sebi.gov.in, www.bseindia.com and www.nseindia.com, respectively, and is available on the websites of the Book Running Lead Managers (“BRLMs”), i.e. JM Financial Limited, Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, HDFC Bank Limited and Kotak Mahindra Capital Company Limited at www.jmfl.com, www.credit-suisse.com, www.goldmansachs.com, www.hdfcbank.comand www.investmentbank.kotak.com, respectively. Potential investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, see “Risk Factors” beginning on page 18 of the DRHP. Potential investors should not rely on the DRHP for making any investment decision.
The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (“U.S. Securities Act”) or any state securities laws in the United States, and unless so registered may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold (i) outside of the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii) to “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act), pursuant to the private placement exemption set out in Section 4(a) of the U.S. Securities Act.
Corporate Comm India(CCI Newswire)
